175 related articles for article (PubMed ID: 2162789)
1. Pituitary-adrenal responses to corticotropin-releasing factor in late onset 21-hydroxylase deficiency.
Carmina E; Lobo RA
Fertil Steril; 1990 Jul; 54(1):79-83. PubMed ID: 2162789
[TBL] [Abstract][Full Text] [Related]
2. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[TBL] [Abstract][Full Text] [Related]
3. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
[TBL] [Abstract][Full Text] [Related]
4. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
Moreira AC; Elias LL
J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
[TBL] [Abstract][Full Text] [Related]
5. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
Siegel SF; Finegold DN; Lanes R; Lee PA
N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
[TBL] [Abstract][Full Text] [Related]
6. Screening for late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Khandekar S; Lata V; Dash RJ
Indian J Med Res; 1990 Apr; 92():79-82. PubMed ID: 2164496
[TBL] [Abstract][Full Text] [Related]
7. Screening heterozygotes for 21-hydroxylase deficiency among hirsute women: lack of utility of the adrenocorticotropin hormone test.
Dewailly D; Vantyghem MC; Lemaire C; Dufosse F; Racadot A; Fossati P
Fertil Steril; 1988 Aug; 50(2):228-32. PubMed ID: 2840308
[TBL] [Abstract][Full Text] [Related]
8. The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency).
Carmina E; Gagliano AM; Rosato F; Maggiore M; Jannì A
J Endocrinol Invest; 1984 Apr; 7(2):89-92. PubMed ID: 6327799
[TBL] [Abstract][Full Text] [Related]
9. [Partial deficiency in 21-hydroxylase in certain forms of hirsutism].
Lucisano A; Satta MA; Tripodi R; Mobili L; De Cicco F; Monaco F; Dell'Acqua S; Roche J
C R Seances Soc Biol Fil; 1989; 183(2):117-21. PubMed ID: 2555033
[TBL] [Abstract][Full Text] [Related]
10. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES
J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
[TBL] [Abstract][Full Text] [Related]
11. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
Azziz R; Bradley EL; Potter HD; Boots LR
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
[TBL] [Abstract][Full Text] [Related]
12. HLA and hormonal studies in 5 patients with late-onset 21-hydroxylase deficiency syndrome (21OHDS).
Scaroni C; Orlandini E; Venturi Pasini C; Gangemi M; Mantero F
J Endocrinol Invest; 1986 Feb; 9(1):65-70. PubMed ID: 3009598
[TBL] [Abstract][Full Text] [Related]
13. 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis.
Azziz R; Zacur HA
J Clin Endocrinol Metab; 1989 Sep; 69(3):577-84. PubMed ID: 2547827
[TBL] [Abstract][Full Text] [Related]
14. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea.
Genazzani AD; Bersi C; Luisi S; Fruzzetti F; Malavasi B; Luisi M; Petraglia F; Genazzani AR
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):247-52. PubMed ID: 11595505
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
[TBL] [Abstract][Full Text] [Related]
16. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
De Leo V; la Marca A; Lanzetta D; Cariello PL; D'Antona D; Morgante G
Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
[TBL] [Abstract][Full Text] [Related]
17. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency.
Levine LS; Dupont B; Lorenzen F; Pang S; Pollack M; Oberfield SE; Kohn B; Lerner A; Cacciari E; Mantero F; Cassio A; Scaroni C; Chiumello G; Rondanini GF; Gargantini L; Giovannelli G; Virdis R; Bartolotta E; Migliori C; Pintor C; Tato L; Barboni F; New MI
J Clin Endocrinol Metab; 1981 Dec; 53(6):1193-8. PubMed ID: 6271801
[TBL] [Abstract][Full Text] [Related]
18. The incidence of non-classical 21-hydroxylase deficiency in hirsute adolescent girls.
Akinci A; Yordam N; Ersoy F; Uluşahin N; Oğuz H
Gynecol Endocrinol; 1992 Jun; 6(2):99-106. PubMed ID: 1323921
[TBL] [Abstract][Full Text] [Related]
19. Failure of steroid replacement to consistently normalize pituitary function in congenital adrenal hyperplasia: hormonal and MRI data.
Speiser PW; Heier L; Serrat J; New MI; Nass R
Horm Res; 1995; 44(6):241-6. PubMed ID: 8808008
[TBL] [Abstract][Full Text] [Related]
20. Congenital adrenal hyperplasia due to partial 21-hydroxylase deficiency. A study of five cases.
Bouchard P; Kuttenn F; Mowszowicz I; Schaison G; Raux-Eurin MC; Mauvais-Jarvis P
Acta Endocrinol (Copenh); 1981 Jan; 96(1):107-11. PubMed ID: 6257014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
